The Prevalence and Impacts of Nudix Hydrolase 15 (NUDT15) Gene Variants in Taiwanese Inflammatory Bowel Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age1-25
SponsorNational Taiwan University Hospital
About this trial
The study will include participants who were diagnosed with inflammatory disease and followed up at National Taiwan University Children's Hospital. The investigators will check the NUDT15 gene test, if the participant agrees to do an additional blood test. The result of the gene test will be analyzed and compared with other clinical data.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Participants who are diagnosed with inflammatory bowel disease.
Disqualifiers
Participants who refused to have blood test for NUDT15 gene evaluation.
Trial population
The study included participants who are diagnosed with inflammatory bowel disease at National Taiwan University Children's Hospital and agree to have blood test for NUDT15 gene evaluation.
Trial design
Design model
Case-only
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Neutropenia
Neutropenia is defined as absolute neutrophil count \<1500/microL, and severe neutropenia is defined as absolute neutrophil count \<500/microL.
Time frame
2 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov